These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12193060)

  • 21. Simvastatin inhibits catecholamine secretion and synthesis induced by acetylcholine via blocking Na+ and Ca2+ influx in bovine adrenal medullary cells.
    Matsuda T; Toyohira Y; Ueno S; Tsutsui M; Yanagihara N
    J Pharmacol Exp Ther; 2008 Oct; 327(1):130-6. PubMed ID: 18593956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways.
    Nagaoka T; Hein TW; Yoshida A; Kuo L
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):825-32. PubMed ID: 17251484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-talk between statins and PPARalpha in cardiovascular diseases: clinical evidence and basic mechanisms.
    Paumelle R; Staels B
    Trends Cardiovasc Med; 2008 Apr; 18(3):73-8. PubMed ID: 18436144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hypocholesterolaemic agents on the expression and activity of 3-hydroxy-3-methylglutaryl-CoA reductase in the fat body of the German cockroach.
    Zapata R; Martín D; Piulachs MD; Bellés X
    Arch Insect Biochem Physiol; 2002 Apr; 49(4):177-86. PubMed ID: 11921076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells.
    Verhulst A; D'Haese PC; De Broe ME
    J Am Soc Nephrol; 2004 Sep; 15(9):2249-57. PubMed ID: 15339974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
    Hu WL; Qiao SB; Li JJ
    Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway.
    Hiraoka M; Nitta N; Nagai M; Shimokado K; Yoshida M
    Life Sci; 2004 Jul; 75(11):1333-41. PubMed ID: 15234191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of macrophage elastase (MMP-12) gene expression by statins.
    Arikan MC; Shapiro SD; Mariani TJ
    J Cell Physiol; 2005 Jul; 204(1):139-45. PubMed ID: 15605420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of the HMG-CoA reductase inhibitor lovastatin and nitric oxide in cardiomyocyte cell death.
    Rabkin SW; Tsang MY
    Pharmacology; 2008; 82(1):74-82. PubMed ID: 18504415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells.
    Laurora S; Pizzimenti S; Briatore F; Fraioli A; Maggio M; Reffo P; Ferretti C; Dianzani MU; Barrera G
    J Pharmacol Exp Ther; 2003 Jun; 305(3):932-42. PubMed ID: 12649303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The possible therapeutic actions of peroxisome proliferator-activated receptor alpha (PPAR alpha) agonists, PPAR gamma agonists, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, angiotensin converting enzyme (ACE) inhibitors and calcium (Ca)-antagonists on vascular endothelial cells.
    Inoue I; Katayama S
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Mar; 4(1):35-52. PubMed ID: 15032651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway.
    Dimitroulakos J; Lorimer IA; Goss G
    Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4426s-4431s. PubMed ID: 16857822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selenoproteins, cholesterol-lowering drugs, and the consequences: revisiting of the mevalonate pathway.
    Moosmann B; Behl C
    Trends Cardiovasc Med; 2004 Oct; 14(7):273-81. PubMed ID: 15542379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compactin-a review.
    Chakravarti R; Sahai V
    Appl Microbiol Biotechnol; 2004 Jun; 64(5):618-24. PubMed ID: 15034683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cells.
    Inoue I; Goto S; Mizotani K; Awata T; Mastunaga T; Kawai S; Nakajima T; Hokari S; Komoda T; Katayama S
    Life Sci; 2000 Jul; 67(8):863-76. PubMed ID: 10946846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eicosapentaenoic acid reduces thrombin-evoked release of endothelin-1 in cultured bovine endothelial cells.
    Jamin SP; Crabos M; Catheline M; Martin-Chouly C; Legrand AB; Saïag B
    Res Commun Mol Pathol Pharmacol; 1999; 105(3):271-81. PubMed ID: 10954131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor activators inhibit oxidized low-density lipoprotein-induced endothelin-1 secretion in endothelial cells.
    Martin-Nizard F; Furman C; Delerive P; Kandoussi A; Fruchart JC; Staels B; Duriez P
    J Cardiovasc Pharmacol; 2002 Dec; 40(6):822-31. PubMed ID: 12451315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins.
    Essig M; Nguyen G; Prié D; Escoubet B; Sraer JD; Friedlander G
    Circ Res; 1998 Oct; 83(7):683-90. PubMed ID: 9758637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simvastatin and Ca(2+) signaling in endothelial cells: involvement of rho protein.
    Alvarez de Sotomayor M; Andriantsitohaina R
    Biochem Biophys Res Commun; 2001 Jan; 280(2):486-90. PubMed ID: 11162544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR.
    Mujumdar VS; Tummalapalli CM; Aru GM; Tyagi SC
    Am J Physiol Cell Physiol; 2002 May; 282(5):C1009-15. PubMed ID: 11940516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.